Invention Grant
- Patent Title: Aryloxy and arylalkyleneoxy substituted imidazoquinolines
- Patent Title (中): 芳氧基和芳基亚烷氧基取代的咪唑并喹啉
-
Application No.: US10595103Application Date: 2004-08-27
-
Publication No.: US07897597B2Publication Date: 2011-03-01
- Inventor: Kyle J. Lindstrom , Hugues M. H. Martin , Bryon A. Merrill , Michael J. Rice , Joshua R. Wurst , Chad A. Haraldson , Tushar A. Kshirsagar , Philip D. Heppner , Shri Niwas , George W. Griesgraber , Matthew R. Radmer
- Applicant: Kyle J. Lindstrom , Hugues M. H. Martin , Bryon A. Merrill , Michael J. Rice , Joshua R. Wurst , Chad A. Haraldson , Tushar A. Kshirsagar , Philip D. Heppner , Shri Niwas , George W. Griesgraber , Matthew R. Radmer
- Applicant Address: US MN St. Paul
- Assignee: 3M Innovative Properties Company
- Current Assignee: 3M Innovative Properties Company
- Current Assignee Address: US MN St. Paul
- International Application: PCT/US2004/028021 WO 20040827
- International Announcement: WO2005/020999 WO 20050310
- Main IPC: A61K31/541
- IPC: A61K31/541 ; A61K31/5377 ; A61K31/496 ; A61K31/4745 ; C07D471/02
Abstract:
Imidazoquinoline compounds with an aryloxy or arylalkyleneoxy or hydroxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
Public/Granted literature
- US20090018122A1 Aryloxy and Arylalkyleneoxy Substituted Imidazoquinolines Public/Granted day:2009-01-15
Information query
